Jiangxi Provincial Cancer Hospital
3 clinical trials · 3 recruiting · OTHER
Trials by Jiangxi Provincial Cancer Hospital
RECRUITINGNCT06268600
The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma
This study aimed to reduce radiation-induced thyroid injury without compromising control of the cervical region by optimizing the delineation of the cervical lymph node drainage...
Sponsor: Jiangxi Provincial Cancer HospitalEnrolling: 3201 location
Nasopharyngeal CarcinomaNasopharyngeal CancerHypothyroidism
RECRUITINGPhase 3NCT06752239
Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC
This study is a multicenter, non-inferiority, open-label, randomized controlled Phase III clinical trial. It aims to compare the efficacy of modified delineation radiotherapy...
Sponsor: Jiangxi Provincial Cancer HospitalEnrolling: 4741 location
Nasopharyngeal CarcinomaQuality of LifeThyroid Diseases+2
RECRUITINGPhase 2NCT05252078
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
This is an Open, Single Arm, Exploratory and Phase II Clinical Trial of Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma...
Sponsor: Jiangxi Provincial Cancer HospitalEnrolling: 301 location
Esophageal Squamous Cell CarcinomaEsophageal NeoplasmsEsophageal Diseases+8